rs1059394
|
|
0.925 |
0.080 |
18 |
672792 |
3 prime UTR variant
|
C/T
|
snv
|
|
0.40
|
Glioma
|
0.020 |
1.000 |
2 |
2019 |
2019 |
rs2847153
|
|
0.925 |
0.080 |
18 |
661647 |
intron variant
|
G/A
|
snv
|
|
0.22
|
Glioma
|
0.020 |
1.000 |
2 |
2019 |
2019 |
rs34743033
|
|
0.776 |
0.200 |
18 |
657657 |
5 prime UTR variant
|
GGCCTGCCTCCGTCCCGCCGCGCCACTTGGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCCC/CGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCG;CGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCG;CGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCG
|
delins
|
|
|
Stomatitis
|
0.020 |
0.500 |
2 |
2013 |
2018 |
rs1059394
|
|
0.925 |
0.080 |
18 |
672792 |
3 prime UTR variant
|
C/T
|
snv
|
|
0.40
|
Sporadic Breast Carcinoma
|
0.010 |
1.000 |
1 |
2015 |
2015 |
rs151264360
|
|
0.925 |
0.040 |
18 |
673444 |
3 prime UTR variant
|
AAGTTA/-;AAGTTAAAGTTA
|
delins
|
|
|
Oral Mucositis
|
0.010 |
< 0.001 |
1 |
2018 |
2018 |
rs151264360
|
|
0.925 |
0.040 |
18 |
673444 |
3 prime UTR variant
|
AAGTTA/-;AAGTTAAAGTTA
|
delins
|
|
|
Hyponatremia
|
0.010 |
1.000 |
1 |
2018 |
2018 |
rs151264360
|
|
0.925 |
0.040 |
18 |
673444 |
3 prime UTR variant
|
AAGTTA/-;AAGTTAAAGTTA
|
delins
|
|
|
Stomatitis
|
0.010 |
< 0.001 |
1 |
2018 |
2018 |
rs2606241
|
|
1.000 |
0.080 |
18 |
657443 |
intron variant
|
A/C
|
snv
|
|
0.66
|
Hyalinosis, Systemic
|
0.010 |
1.000 |
1 |
2019 |
2019 |
rs2790
|
|
0.925 |
0.160 |
18 |
673086 |
3 prime UTR variant
|
A/G;T
|
snv
|
|
0.22
|
Acute lymphocytic leukemia
|
0.010 |
1.000 |
1 |
2018 |
2018 |
rs2790
|
|
0.925 |
0.160 |
18 |
673086 |
3 prime UTR variant
|
A/G;T
|
snv
|
|
0.22
|
Sporadic Breast Carcinoma
|
0.010 |
1.000 |
1 |
2015 |
2015 |
rs2847149
|
|
1.000 |
0.080 |
18 |
666371 |
intron variant
|
G/A
|
snv
|
|
0.55
|
Spina Bifida
|
0.010 |
1.000 |
1 |
2009 |
2009 |
rs2847153
|
|
0.925 |
0.080 |
18 |
661647 |
intron variant
|
G/A
|
snv
|
|
0.22
|
Lymphocyte Count measurement
|
0.700 |
1.000 |
1 |
2012 |
2012 |
rs2847153
|
|
0.925 |
0.080 |
18 |
661647 |
intron variant
|
G/A
|
snv
|
|
0.22
|
Non-Small Cell Lung Carcinoma
|
0.010 |
1.000 |
1 |
2015 |
2015 |
rs2853542
|
|
1.000 |
0.120 |
18 |
657685 |
5 prime UTR variant
|
G/C;T
|
snv
|
|
|
Childhood Acute Lymphoblastic Leukemia
|
0.010 |
1.000 |
1 |
2018 |
2018 |
rs2853741
|
|
1.000 |
0.080 |
18 |
657352 |
intron variant
|
T/C;G
|
snv
|
|
|
Hyalinosis, Systemic
|
0.010 |
1.000 |
1 |
2019 |
2019 |
rs34743033
|
|
0.776 |
0.200 |
18 |
657657 |
5 prime UTR variant
|
GGCCTGCCTCCGTCCCGCCGCGCCACTTGGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCCC/CGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCG;CGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCG;CGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCG
|
delins
|
|
|
Neutropenia
|
0.010 |
1.000 |
1 |
2015 |
2015 |
rs34743033
|
|
0.776 |
0.200 |
18 |
657657 |
5 prime UTR variant
|
GGCCTGCCTCCGTCCCGCCGCGCCACTTGGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCCC/CGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCG;CGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCG;CGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCG
|
delins
|
|
|
Colorectal Carcinoma
|
0.010 |
1.000 |
1 |
2013 |
2013 |
rs34743033
|
|
0.776 |
0.200 |
18 |
657657 |
5 prime UTR variant
|
GGCCTGCCTCCGTCCCGCCGCGCCACTTGGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCCC/CGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCG;CGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCG;CGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCG
|
delins
|
|
|
Stomach Carcinoma
|
0.010 |
1.000 |
1 |
2017 |
2017 |
rs34743033
|
|
0.776 |
0.200 |
18 |
657657 |
5 prime UTR variant
|
GGCCTGCCTCCGTCCCGCCGCGCCACTTGGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCCC/CGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCG;CGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCG;CGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCG
|
delins
|
|
|
Oral Mucositis
|
0.010 |
< 0.001 |
1 |
2018 |
2018 |
rs34743033
|
|
0.776 |
0.200 |
18 |
657657 |
5 prime UTR variant
|
GGCCTGCCTCCGTCCCGCCGCGCCACTTGGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCCC/CGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCG;CGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCG;CGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCG
|
delins
|
|
|
Retinoblastoma
|
0.010 |
1.000 |
1 |
2016 |
2016 |
rs34743033
|
|
0.776 |
0.200 |
18 |
657657 |
5 prime UTR variant
|
GGCCTGCCTCCGTCCCGCCGCGCCACTTGGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCCC/CGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCG;CGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCG;CGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCG
|
delins
|
|
|
Leukopenia
|
0.010 |
1.000 |
1 |
2015 |
2015 |
rs34743033
|
|
0.776 |
0.200 |
18 |
657657 |
5 prime UTR variant
|
GGCCTGCCTCCGTCCCGCCGCGCCACTTGGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCCC/CGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCG;CGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCG;CGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCG
|
delins
|
|
|
Malignant neoplasm of stomach
|
0.010 |
1.000 |
1 |
2017 |
2017 |
rs3891167
|
|
|
|
18 |
658423 |
non coding transcript exon variant
|
A/G
|
snv
|
|
0.26
|
Finding of Mean Corpuscular Hemoglobin
|
0.700 |
1.000 |
1 |
2019 |
2019 |
rs502396
|
|
1.000 |
0.080 |
18 |
659236 |
intron variant
|
C/T
|
snv
|
|
0.46
|
Spina Bifida
|
0.010 |
1.000 |
1 |
2009 |
2009 |
rs502396
|
|
1.000 |
0.080 |
18 |
659236 |
intron variant
|
C/T
|
snv
|
|
0.46
|
Neural Tube Defects
|
0.010 |
1.000 |
1 |
2012 |
2012 |